Controle glicêmico e lipídico de pacientes com diabete tipo 2 em tratamento combinado de metformina e insulina

Content Provider	Semantic Scholar
Copyright Year	2010
Abstract	This transverse study was undertaken to assess serum lipoprotein cholesterol, glycated hemoglobin (HbA1c) and triglyceride levels of 105 patients with type 2 diabetes mellitus in insulin use belonging to a health care area of the Family Health Program (FHP). It had as objective to identify possible variations in those parameters when metformin is associated to the treatment. Thirty-three of those patients were excluded by presenting inclinations. Of the remaining, 44 subjects were on combination therapy of metformin and insulin – these indicated serum levels of HbA1c and triglycerides significantly lower than the control group in treatment with insulin alone (n=28); statistical differences were not observed regarding high-density lipoprotein and total cholesterol levels. The research appeared that, due to free readiness of metformin for the population, combined therapy should be used as first choice in public health.
Starting Page	33
Ending Page	37
Page Count	5
File Format	PDF HTM / HTML
DOI	10.5712/rbmfc5(17)200
Volume Number	5
Alternate Webpage(s)	https://rbmfc.emnuvens.com.br/rbmfc/article/download/200/152
Alternate Webpage(s)	https://doi.org/10.5712/rbmfc5%2817%29200
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article